Administration of osimertinib to mice reduced tumor volume in those with high levels of miR-204, leading to a lower number of Ki67+ (proliferation marker protein Ki-67) cells and increased apoptosis in these xenograft cells [99]. The gene discussed is MKI67; the disease is neoplasm.